Drugs / FT836 CAR T cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07221032 | Jul 2026 → Mar 2028 expected | plasma cell myeloma | Medical College of Wisconsin | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FT836 CAR T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07221032 ↗ |
| Modality | Cell therapy | “FT836 CAR T cells” NCT07221032 ↗ |
| Route | Intravenous | “FT836 CAR T cells will be administered by IV injection.” NCT07221032 ↗ |